RxDoctor Payments DataLook up a doctor →

Padma Mahant, MD

Neurology · Phoenix, AZNPI 1053310227

Payments from drug & device makers

$232,246in general payments, 2019–2025

Across 1,148 payments — averaging $202.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acorda Therapeutics, Inc$66K
  • Teva Pharmaceuticals USA, Inc.$64K
  • Amneal Pharmaceuticals LLC$41K
  • MDD US Operations, LLC$30K
  • Lundbeck LLC$9K
  • AbbVie$6K
  • plus $16K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acorda Therapeutics, Inc144$66,234
Teva Pharmaceuticals USA, Inc.97$64,141
Amneal Pharmaceuticals LLC73$40,631
MDD US Operations, LLC95$30,121
Lundbeck LLC34$8,630
AbbVie(2 entities)203$6,173
Medtronic(2 entities)65$4,817
Sunovion Pharmaceuticals Inc.17$2,304
Acadia Pharmaceuticals Inc12$1,036
Boston Scientific7$800
UCB, Inc.64$798
Neurocrine Biosciences, Inc.29$760
Amgen(2 entities)27$493
Kyowa Kirin, Inc.25$468
Lilly USA, LLC26$462
Biogen24$430
Novartis23$383
Argenx US, Inc.12$275
Sanofi15$268
Eisai Inc.11$266
Merz Pharmaceuticals, LLC7$235
Avion Pharmaceuticals12$195
Abbott9$181
Upsher-smith Laboratories LLC11$173
Genentech USA, Inc.6$167
AstraZeneca8$166
CSL Behring5$137
Supernus Pharmaceuticals, Inc.3$96
Mallinckrodt Hospital Products Inc.5$92
Banner Life Sciences, LLC5$83
Jazz Pharmaceuticals Inc.5$83
Averitas Pharma Inc.3$72
Neurelis, Inc.4$71
Pfizer3$63
Merz North America, Inc.3$59
Bristol Myers Squibb3$55
Biohaven Pharmaceutical Holding Company Ltd.2$49
Otsuka America Pharmaceutical, Inc.2$45
EMD Serono, Inc.2$41
Bausch Health US, LLC3$41
E.r. Squibb & Sons, L.L.C.3$40
Microtransponder, Inc.1$39
Harmony Biosciences LLC2$38
Mallinckrodt Enterprises LLC2$37
Idorsia Pharmaceuticals US Inc2$36
Johnson & Johnson2$36
ANI Pharmaceuticals, Inc.2$35
Nevro Corp.2$32
Scilex Pharmaceuticals Inc.2$30
Sanofi-aventis U.S. LLC2$28
Assertio Therapeutics, Inc.2$26
Otto Bock Healthcare LP1$24
Kestra Medical Technology Services, Inc.1$24
Shire North American Group Inc1$22
Impel Pharmaceuticals Inc.1$20
Aucta Pharmaceuticals, Inc.2$20
Cycle Pharmaceuticals Inc1$19
GRT US Holding, Inc.1$19
Promius Pharma LLC1$17
Tonix Medicines, Inc.1$16

How this compares

$232,246 in reported general payments places this provider in the 85th percentile of 388 neurology providers in Arizona.

See all neurology providers in Arizona →

Medicare billing

Part B allowed, 2024
$149,738
Medicare patients
174
Services billed
11,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Phoenix

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →